Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The unmet need for chemotherapy induced diarrhea is a 2 billion+ market so a 500 million market cap is more than reasonable.
Care to explain the rationale behind your 'target price'??
Be interested to know how many are believed to NEED (could use) this development
what price you see it selling at..
Their profit margins, how many would be repeat customers vs using it a time or two.
for you are talking about around a $500 Million MARKET CAP at $100.
I'm a thinking at this stage, with the lack of data, $50 Mil MIGHT be possible.. Thats roughly $10/sh (or the 60 CENTS per share
thats been on Yahoo as a 'target price')... and I have no idea where that number came from
...based on what? This is not a cure for cancer, let's be honest.
Successful phase 3 ,can realistically push this towards $100.00
pushing $5 in the AH??? Pretty steady activity vs a few minutes of trading.. Like it... Hmmm..
1 Million shares have changed hands today. Unreal... 25% of the float appears to have changed hands, it was 1 Million shares plus
yesterday as well.
That is a lot of churning taking place for a 5 Million share float..
Disclaimer: Just bought 500 shares at $4.73. Why? Market cap hit, prospects for the PH 3 to be 'acceptable', tight float.
Yes, it could dip some more, yes, there could be a secondary offering in the works, but I think they will hold off doing one
until after the PH3 data is released (less shares at a higher share price?)
Could have gone a lot more, but, not getting greedy cause if this drops to sub $4, I likely will add to this buy.
Good luck..
OK, the question is, how BALLSY are the short sellers going to be. With only 5 Million shares in the float, one hint of good news
and those short could be toast due to the very tight float.
And now that it has been 'hit hard' post the split (about 8 cents pre the 1-60), with a market cap of less than $25 Million??
IF that PH 3 news is good, this could easily see the share price back to support a market cap of $40-50 Million. IE, a double
in the share price from this level.
So I don't think there will be that many short sellers (unless they are naked selling) putting themselves in harms way from this price and lower
with the threat of the PH 3 facing them. But it not unlikely that shareholders watching the price get walked down start to capitulate, say enough
and help walk the price lower.
Sentiment indicator I use thats been running 100% positive for over a month cracked today and slipped into the negative zone. Indicating
the BUYERS are drying up..
Disclaimer: own none, but with the collapsing market cap, it getting real tempting.. to see what happens when the ph 3 data is released, if its good
Posting old literature is not helping the company or shareholders.Approvals and contracts equal revenue,which then translates to profit,is what's needed.The company has not keep the shareholders in the loop on any of these.Instead has orchestrated a RS and now is focusing on implementing a share increase.All of which has had a negative effect on the share price.Unless they come out with some positive news,I don't see it improving anytime soon.Good luck and good trading.
Substantial pipeline..... https://jaguar.health/pipeline/
This has no business @ or around $0.10 .....More like $10 - $12 .....UNDERVALUED!!!
100% Agreeee I put buy order at 12 cents for 60 days. That’s all it worth
Funny how tt2016 agrees with us DT and we agree with him now
this will be a great short
I guess we all can be friends today
I was promised some abstracts...
Looks like when we get down to .10 cents again I will look for another entry. We will probably be there in a couple of months. Amazing how fast this dropped today.
Funny how bears come out the wood works 45 min from ASCO abstract release. Try again #bagsloaded
After 4pm CST, 5pm ET, this is going to fly once the abstracts are posted on ASCO, we are talking Gelcair & PH 3 abstracts. 🕊️
It's going lower.There is nothing to prop it up.The management is MIA right now.They will increase the share count to do another offering.More dilution coming in the not to distant future.Good luck and good trading.
Actually, with the MARKET CAP crashing down to between 25 & 30 Million?? This is getting interesting, enticing.
Cause a bounce to a $50 Mil market cap would be about an 75% gain... and if they can justify a $100 Mil cap??
Only concern is, do they need to raise cash to bring the PH 3 results to market..
IE, will dilution occur (I suspect it will and how much of hit on the share price could it have)
Disclaimer: I still can't bring myself to buy shares at this price level. Just too tempting for those that ignore how
hard the market cap has gotten hit since it peaked at around $19/sh (based on the 1-60 equivalent)
More pain coming,this is just the beginning.RS's and increases in share counts,never go over well.Good luck and good trading.
Dropping faster than I thought can you imagine having your own unlimited ATM
Can it justify a $50 Million MARKET CAP? If so, thats about a 80% return from the current share price..
Unfortunately, I suspect the market isn't going to care about how cheap the market cap gets, won't be paying attention to what it 'is'.. That it
will initially just focus on attacking the share price to drive it lower. With the negative aura a reverse split impresses on
potential buyers, I am left to wonder how fall the share price is going to get taken down to.
Oh well she could not possibly be bull shitting... like when she said Phase III results before Thanksgiving... opps wait that was wrong... it was during the first quarter of 2024... oh rats that was wrong again... it was soon... no wait there was a snafu when the data was run... so it was moved again, then a few months passed and she said imminent and now the RS took effect and they mention the ACS convention and they are talking about a gel no mention of the Phase III and here it is One Full hour in and from $8.00 to $5.00
How much bull shit can the average Jaguar Share Holder eat... seems like a truck load if you believe a sings word this women says...
[quoteWell the EMAIL literally said phase 3 results are imminent, and lisa signed off the letter with "ALL THE BEST"][/quote]
Have you been living under a rock...look at JAGX website orrrr any stock news sites.
what happened to my shares? Where did they do? what a scam
down to 10 cents now... getting really attractive...
from a MARKET CAP perspective... now down to around $30 Million..
MAY 23, 2024 at 5:00 PM (ET)
Majority of abstracts are released on asco.org/abstracts (Late-breaking Abstracts will be released at 7:00 AM CT on their day of presentation at the meeting)
MAY 31 - JUNE 4, 2024
ASCO Annual Meeting (Chicago, IL)
They did mentioned PIII, they are just vague if they will be available in time for the conference.
""We look forward to driving awareness among oncologists at the ASCO Annual Meeting about Gelclair and Jaguar's expanding focus on cancer supportive care," said Conte. "The depth of our commitment to people living with a cancer diagnosis is further exemplified by the 5-year commitment we've made to clinically study prophylaxis of cancer therapy-related diarrhea with our phase 3 OnTarget trial - specifically focusing on the more than 24 targeted cancer agents that have an incidence of greater than 50% diarrhea. Top line results from this pivotal study are imminent."
Again with the "imminent". Someone should ask her what imminent means in her vocabulary. Days? Weeks? Months? It's been 10 days already since she first mentioned the results being "imminent" and not "forthcoming".
Well the EMAIL literally said phase 3 results are imminent, and lisa signed off the letter with "ALL THE BEST"
100% Agreeee she make money only from selling shares unlimited ATM it will drop to below 60 cents in a week lucky who can short it I never play that game
I doubt it... the PR today mentioned only one subject for the upcoming Conference and nothing about the Phase III... Lisia is setting this up for failuar once again... That PR is going to cause a sell off because far to many are thinking Phase III results will be announce and discussed at that exact conference.
Either way, this won't be in effect until the shareholders' meeting, 21 June. They better release those damn results asap... "imminent" my ass.
The number of shares of our common stock to be outstanding after this offering is based on 4,889,226 shares of our voting common stock and no shares of our non-voting common stock outstanding as of May 15, 2024, and excludes the following:
•
76,198 shares of common stock issuable upon exercise of warrants outstanding, with a weighted-average exercise price of $38.69;
?
•
435 shares of common stock issuable upon exercise of outstanding options under the 2014 Stock Incentive Plan, with a weighted-average exercise price of $36,701;
?
•
25 shares of common stock issuable upon exercise of outstanding options under the 2020 Employee Inducement Plan, with a weighted-average exercise price of $20,770;
?
•
63,637 shares of common stock that remain available for grant under the 2014 Stock Incentive Plan and 8,084 shares of common stock that remain available under the 2020 Employee Inducement Plan; and
?
•
44,801 and 175 shares of common stock issuable upon vesting of outstanding restricted stock unit awards (“RSUs”) under the 2014 Stock Incentive Plan and 2020 Employee Inducement Plan, respectively;
When I first bought JAGX the share total was about 7 million shares. She diluted hundreds of million shares in a year. She has proven she has done it after many reverse splits. Just like the last time this could go below $1 again and soon.
Everyone will be watching what a reverse split will do.
If she could just keep from adding new shares now there could be hope, but i do not see it.
She will be taught a lesson today and next week when it drops.
As someone WITHOUT any shares coming into today:
-now we sit back and watch to see what happens to the share price. While it says $7.68 on my screen, its around 12-13 cents.
-the 5 Million share count now if like a tensioned spring waiting to be released IF there is good news forthcoming. A small jump in demand could be result in a fast move in the share price.
The only question is? What happens to the share price post this r/split??
And with only 5 Million or so shares outstanding??
I will not be surprised if they say a secondary/ATM is coming. Believe they have around $11 Million in cash on hand?? Unless they plan to 'borrow' with the prospects of using sales to cover the borrowed funds??
Um... If they authorize the NEW SHARES, don't they COUNT in the TOTAL SHAREs outstanding??
Which means the shares are added to the existing outstanding count? Which means, MORE SHARES IS DILUTION..
If not?? Explain why not..
So where is this pig opening at ? $7.69 ?
Timber, read, that's for the incentive plan, not for dilution
RS halt....that's all dude. No news tomorrow. Maybe next year
They dividing your money by 60 and if a good company they should do the same to the outstanding shares not increase them. Total Rip-off again free ATM to them what a shame
That is correct Timberwolf.Most on this board don't know how to read.The share increase will take place after the RS.Good luck and good trading.
NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS
To Be Held June 21, 2024 4. Approving an amendment and restatement of the Company’s 2014 Stock Incentive Plan (the “2014
Plan”) to increase the number of shares of Common Stock authorized for issuance under the 2014 Plan by
45,500,000 shares (equivalent to 758,333 shares following the 1-for-60 reverse stock split to be effectuated
on May 23, 2024) (Proposal 4)
believe this represents around a 12% (+/- some) DILUTION of the around 4.88 Million shares post the r/split..
looking to see how much cash they have on hand at present...
Pretty sure 5pm ET, the shares get new cussip assignments and you shall see it reflect in share count today. Shall open tomorrow at 60x price it closes at today. Eyes peeled for a 1000x banger. If it doesn't happen today then r/s isn't happening and it was only filed for NASDAQ compliance rules. If we get over $1 they might pull it off the tables. I see no 8k filed or amendments to the certificate. WHERE IS THE R/S??
It will get more than ugly.You think this will stay at 7 or 8 bucks,think again.This will drop like a stone,making your 13 cent shares be more like 3 cent shares.Good luck and good trading.
Followers
|
133
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
6960
|
Created
|
12/01/15
|
Type
|
Free
|
Moderators SmellMyFinger |
Jaguar Health, Inc. $JAGX
Bringing Plant-based Medicines to Life™
Pharmaceutical Manufacturing
San Francisco, California
Jaguar Health’s organizational framework is designed to enable our product pipeline to reach the world’s interconnected marketplace, allowing for development and commercialization opportunities worldwide.
Products:
Mytesi Crofelemer 125mg delayed release tablets
Mytesi is FDA-approved for symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy
Mytesi has a novel mechanism of action that modulates chloride secretion in the gastrointestinal tract, reducing excessive chloride and accompanying water flow and relieving watery diarrhea.
Mytesi is not indicated for the treatment of infectious diarrhea. In clinical studies, the most common adverse reactions occurring at a rate greater than placebo were upper respiratory tract infection (6%), bronchitis (4%), cough (4%), flatulence (3%), and increased bilirubin (3%).
Canalevia-CA1 Crofelemer delayed release tablets
Distributors listed:
https://www.canalevia.com/distributor-information
CANALEVIA-CA1 is conditionally approved for the treatment of chemotherapy-induced diarrhea (CID) in dogs.
Conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-552.
CAUTION: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. It is a violation of Federal Law to use this product other than as directed in the labeling.
Pipeline: https://jaguar.health/pipeline/
About the Jaguar Health Family of Companies
Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, and bowel incontinence.
Jaguar Health https://jaguar.health/
Napo Pharmaceuticals https://napopharma.com/
Napo Therapeutics https://napotherapeutics.com/en/
https://www.magdalenabiosciences.com/
Magdalena is a joint venture formed by Jaguar Health and Filament Health. The company holds an exclusive license to Jaguar's proprietary library of approximately 2,300 highly characterized medicinal plants and 3,500 plant extracts for designated therapeutic indications.
Visit Jaguar on LinkedIn:
https://www.linkedin.com/company/jaguar-health/
Visit Jaguar on Instagram: https://www.instagram.com/jaguarhealthcommunity/
Visit Jaguar on X: https://twitter.com/Jaguar_Health
Phone: 415-371-8300
Contact: hello@jaguar.health
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |